The Analytic and Preparative Flow Cytometry Core (APFCC) is designed to enhance the power andproductivity of the research of Rheumatic Disease Core Center (RDCC) investigators by providing state-ofthe-art flow cytometry for cell analyses and purification at a reasonable cost. To accomplish this goal, theCore provides the equipment, service and expertise necessary for the application of flow cytometry andrelated technologies to cutting edge research in the rheumatic diseases. We have used nationally peerreviewedfederal instrumentation grants and UAB resources to obtain top-of-the-line equipment that providesa wide range of applications for RDCC investigators. This includes a 20-detector, 4-laser analytic cytometer(obtained 2006), a 14-detector, 3-laser, a sort enhanced all digital sorting cytometer (upgraded 2006), a 6-detector, loader equipped analyzer, and a 5-detector analyzer. In addition, the core provides equipment forancillary techniques such as automated sample preparation (acquired 2005), spectrofluorimetry, andautomated magnetic enrichment (acquired 2005). We have developed new techniques as well as providedbasic sample analysis, with the result that the APFCC has served over 120 independently funded UABinvestigators and contributed to many publications. Our goals for the core are to continue efforts at outreachand education, to alert RDCC investigators to the potential for flow technology to increase the power of theirresearch, service, to improve efficiency and to maintain the highest possible standards of quality, andapplication development, to continue to bring new technologies and protocols to the RDCC researchcommunity. To achieve these goals, funds are requested to support outreach, educational, quality controland development activities of the Core Director and Core Manager and partially offset the costs of oneservice contract to maintain uninterrupted access to this vital technology. The-Scientific Advisory Committee,which combines both knowledgeable users and those involved in senior research positions at UAB, anexternal advisory, who is well informed about newer equipment and applications, and an integration with thelarger UAB institution will provide feedback and drive further development. With these efforts, we willmaintain flow cytometry as a fundamental, vital tool for state-of-the-art research in the rheumatic diseases atUAB.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
5P30AR048311-07
Application #
7669289
Study Section
Special Emphasis Panel (ZAR1)
Project Start
2008-09-01
Project End
2012-08-31
Budget Start
2008-09-01
Budget End
2009-08-31
Support Year
7
Fiscal Year
2008
Total Cost
$119,940
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Chen, Wei; Zhu, Guochun; Jules, Joel et al. (2018) Monocyte-Specific Knockout of C/ebp? Results in Osteopetrosis Phenotype, Blocks Bone Loss in Ovariectomized Mice, and Reveals an Important Function of C/ebp? in Osteoclast Differentiation and Function. J Bone Miner Res 33:691-703
Wang, Yong; Schafer, Cara C; Hough, Kenneth P et al. (2018) Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5. J Immunol 201:278-295
Jones, Robert B; Dorsett, Kaitlyn A; Hjelmeland, Anita B et al. (2018) The ST6Gal-I sialyltransferase protects tumor cells against hypoxia by enhancing HIF-1? signaling. J Biol Chem 293:5659-5667
Bandari, Shyam K; Purushothaman, Anurag; Ramani, Vishnu C et al. (2018) Chemotherapy induces secretion of exosomes loaded with heparanase that degrades extracellular matrix and impacts tumor and host cell behavior. Matrix Biol 65:104-118
Jo, SeongHo; Chen, Junqin; Xu, Guanlan et al. (2018) miR-204 Controls Glucagon-Like Peptide 1 Receptor Expression and Agonist Function. Diabetes 67:256-264
Stafman, Laura L; Williams, Adele P; Garner, Evan F et al. (2018) Targeting PIM Kinases Affects Maintenance of CD133 Tumor Cell Population in Hepatoblastoma. Transl Oncol 12:200-208
Hamilton, Jennie A; Wu, Qi; Yang, PingAr et al. (2018) Cutting Edge: Intracellular IFN-? and Distinct Type I IFN Expression Patterns in Circulating Systemic Lupus Erythematosus B Cells. J Immunol 201:2203-2208
Yang, Zhenhua; Shah, Kushani; Busby, Theodore et al. (2018) Hijacking a key chromatin modulator creates epigenetic vulnerability for MYC-driven cancer. J Clin Invest 128:3605-3618
Hough, Kenneth P; Trevor, Jennifer L; Strenkowski, John G et al. (2018) Exosomal transfer of mitochondria from airway myeloid-derived regulatory cells to T cells. Redox Biol 18:54-64
Williams, Adele P; Waters, Alicia M; Stewart, Jerry E et al. (2018) A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro. J Surg Res 228:54-62

Showing the most recent 10 out of 340 publications